The global market for IVD Infectious Disease was valued at US$ 5148 million in the year 2024 and is projected to reach a revised size of US$ 8984 million by 2031, growing at a CAGR of 8.4% during the forecast period.

IVD Infectious Disease Market

In Vitro Diagnosis, or IVD (In Vitro Diagnosis), refers to the product and service of disease or body function that is obtained by testing human samples (blood, body fluids, tissues, etc.).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for IVD Infectious Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVD Infectious Disease.

The IVD Infectious Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global IVD Infectious Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the IVD Infectious Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of IVD Infectious Disease Market Report

Report Metric	Details
Report Name	IVD Infectious Disease Market
Accounted market size in year	US$ 5148 million
Forecasted market size in 2031	US$ 8984 million
CAGR	8.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Biochemical Diagnosis Immune Diagnosis Molecular Diagnosis Microbiological Diagnosis Urine Diagnosis Coagulation Diagnosis Other
Segment by Application	Personal Commercial Academic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche Diagnostics, Abbott Laboratories, Gen-Probe, Becton Dickinson (BD), Bio-Rad Laboratories, Siemens Healthcare, Biomérieux, Danaher, Thermo Fisher, Sysmex
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IVD Infectious Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is IVD Infectious Disease Market growing?

Ans: The IVD Infectious Disease Market witnessing a CAGR of 8.4% during the forecast period 2025-2031.

What is the IVD Infectious Disease Market size in 2031?

Ans: The IVD Infectious Disease Market size in 2031 will be US$ 8984 million.

Who are the main players in the IVD Infectious Disease Market report?

Ans: The main players in the IVD Infectious Disease Market are Roche Diagnostics, Abbott Laboratories, Gen-Probe, Becton Dickinson (BD), Bio-Rad Laboratories, Siemens Healthcare, Biomérieux, Danaher, Thermo Fisher, Sysmex

What are the Application segmentation covered in the IVD Infectious Disease Market report?

Ans: The Applications covered in the IVD Infectious Disease Market report are Personal, Commercial, Academic, Other

What are the Type segmentation covered in the IVD Infectious Disease Market report?

Ans: The Types covered in the IVD Infectious Disease Market report are Biochemical Diagnosis, Immune Diagnosis, Molecular Diagnosis, Microbiological Diagnosis, Urine Diagnosis, Coagulation Diagnosis, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global IVD Infectious Disease Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Biochemical Diagnosis

1.2.3 Immune Diagnosis

1.2.4 Molecular Diagnosis

1.2.5 Microbiological Diagnosis

1.2.6 Urine Diagnosis

1.2.7 Coagulation Diagnosis

1.2.8 Other

1.3 Market by Application

1.3.1 Global IVD Infectious Disease Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Personal

1.3.3 Commercial

1.3.4 Academic

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global IVD Infectious Disease Market Perspective (2020-2031)

2.2 Global IVD Infectious Disease Growth Trends by Region

2.2.1 Global IVD Infectious Disease Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 IVD Infectious Disease Historic Market Size by Region (2020-2025)

2.2.3 IVD Infectious Disease Forecasted Market Size by Region (2026-2031)

2.3 IVD Infectious Disease Market Dynamics

2.3.1 IVD Infectious Disease Industry Trends

2.3.2 IVD Infectious Disease Market Drivers

2.3.3 IVD Infectious Disease Market Challenges

2.3.4 IVD Infectious Disease Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top IVD Infectious Disease Players by Revenue

3.1.1 Global Top IVD Infectious Disease Players by Revenue (2020-2025)

3.1.2 Global IVD Infectious Disease Revenue Market Share by Players (2020-2025)

3.2 Global IVD Infectious Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by IVD Infectious Disease Revenue

3.4 Global IVD Infectious Disease Market Concentration Ratio

3.4.1 Global IVD Infectious Disease Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by IVD Infectious Disease Revenue in 2024

3.5 Global Key Players of IVD Infectious Disease Head office and Area Served

3.6 Global Key Players of IVD Infectious Disease, Product and Application

3.7 Global Key Players of IVD Infectious Disease, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 IVD Infectious Disease Breakdown Data by Type

4.1 Global IVD Infectious Disease Historic Market Size by Type (2020-2025)

4.2 Global IVD Infectious Disease Forecasted Market Size by Type (2026-2031)

5 IVD Infectious Disease Breakdown Data by Application

5.1 Global IVD Infectious Disease Historic Market Size by Application (2020-2025)

5.2 Global IVD Infectious Disease Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America IVD Infectious Disease Market Size (2020-2031)

6.2 North America IVD Infectious Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America IVD Infectious Disease Market Size by Country (2020-2025)

6.4 North America IVD Infectious Disease Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe IVD Infectious Disease Market Size (2020-2031)

7.2 Europe IVD Infectious Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe IVD Infectious Disease Market Size by Country (2020-2025)

7.4 Europe IVD Infectious Disease Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific IVD Infectious Disease Market Size (2020-2031)

8.2 Asia-Pacific IVD Infectious Disease Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific IVD Infectious Disease Market Size by Region (2020-2025)

8.4 Asia-Pacific IVD Infectious Disease Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America IVD Infectious Disease Market Size (2020-2031)

9.2 Latin America IVD Infectious Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America IVD Infectious Disease Market Size by Country (2020-2025)

9.4 Latin America IVD Infectious Disease Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa IVD Infectious Disease Market Size (2020-2031)

10.2 Middle East & Africa IVD Infectious Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa IVD Infectious Disease Market Size by Country (2020-2025)

10.4 Middle East & Africa IVD Infectious Disease Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche Diagnostics

11.1.1 Roche Diagnostics Company Details

11.1.2 Roche Diagnostics Business Overview

11.1.3 Roche Diagnostics IVD Infectious Disease Introduction

11.1.4 Roche Diagnostics Revenue in IVD Infectious Disease Business (2020-2025)

11.1.5 Roche Diagnostics Recent Development

11.2 Abbott Laboratories

11.2.1 Abbott Laboratories Company Details

11.2.2 Abbott Laboratories Business Overview

11.2.3 Abbott Laboratories IVD Infectious Disease Introduction

11.2.4 Abbott Laboratories Revenue in IVD Infectious Disease Business (2020-2025)

11.2.5 Abbott Laboratories Recent Development

11.3 Gen-Probe

11.3.1 Gen-Probe Company Details

11.3.2 Gen-Probe Business Overview

11.3.3 Gen-Probe IVD Infectious Disease Introduction

11.3.4 Gen-Probe Revenue in IVD Infectious Disease Business (2020-2025)

11.3.5 Gen-Probe Recent Development

11.4 Becton Dickinson (BD)

11.4.1 Becton Dickinson (BD) Company Details

11.4.2 Becton Dickinson (BD) Business Overview

11.4.3 Becton Dickinson (BD) IVD Infectious Disease Introduction

11.4.4 Becton Dickinson (BD) Revenue in IVD Infectious Disease Business (2020-2025)

11.4.5 Becton Dickinson (BD) Recent Development

11.5 Bio-Rad Laboratories

11.5.1 Bio-Rad Laboratories Company Details

11.5.2 Bio-Rad Laboratories Business Overview

11.5.3 Bio-Rad Laboratories IVD Infectious Disease Introduction

11.5.4 Bio-Rad Laboratories Revenue in IVD Infectious Disease Business (2020-2025)

11.5.5 Bio-Rad Laboratories Recent Development

11.6 Siemens Healthcare

11.6.1 Siemens Healthcare Company Details

11.6.2 Siemens Healthcare Business Overview

11.6.3 Siemens Healthcare IVD Infectious Disease Introduction

11.6.4 Siemens Healthcare Revenue in IVD Infectious Disease Business (2020-2025)

11.6.5 Siemens Healthcare Recent Development

11.7 Biomérieux

11.7.1 Biomérieux Company Details

11.7.2 Biomérieux Business Overview

11.7.3 Biomérieux IVD Infectious Disease Introduction

11.7.4 Biomérieux Revenue in IVD Infectious Disease Business (2020-2025)

11.7.5 Biomérieux Recent Development

11.8 Danaher

11.8.1 Danaher Company Details

11.8.2 Danaher Business Overview

11.8.3 Danaher IVD Infectious Disease Introduction

11.8.4 Danaher Revenue in IVD Infectious Disease Business (2020-2025)

11.8.5 Danaher Recent Development

11.9 Thermo Fisher

11.9.1 Thermo Fisher Company Details

11.9.2 Thermo Fisher Business Overview

11.9.3 Thermo Fisher IVD Infectious Disease Introduction

11.9.4 Thermo Fisher Revenue in IVD Infectious Disease Business (2020-2025)

11.9.5 Thermo Fisher Recent Development

11.10 Sysmex

11.10.1 Sysmex Company Details

11.10.2 Sysmex Business Overview

11.10.3 Sysmex IVD Infectious Disease Introduction

11.10.4 Sysmex Revenue in IVD Infectious Disease Business (2020-2025)

11.10.5 Sysmex Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global IVD Infectious Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Biochemical Diagnosis

Table 3. Key Players of Immune Diagnosis

Table 4. Key Players of Molecular Diagnosis

Table 5. Key Players of Microbiological Diagnosis

Table 6. Key Players of Urine Diagnosis

Table 7. Key Players of Coagulation Diagnosis

Table 8. Key Players of Other

Table 9. Global IVD Infectious Disease Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global IVD Infectious Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global IVD Infectious Disease Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global IVD Infectious Disease Market Share by Region (2020-2025)

Table 13. Global IVD Infectious Disease Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global IVD Infectious Disease Market Share by Region (2026-2031)

Table 15. IVD Infectious Disease Market Trends

Table 16. IVD Infectious Disease Market Drivers

Table 17. IVD Infectious Disease Market Challenges

Table 18. IVD Infectious Disease Market Restraints

Table 19. Global IVD Infectious Disease Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global IVD Infectious Disease Market Share by Players (2020-2025)

Table 21. Global Top IVD Infectious Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Disease as of 2024)

Table 22. Ranking of Global Top IVD Infectious Disease Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by IVD Infectious Disease Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of IVD Infectious Disease, Headquarters and Area Served

Table 25. Global Key Players of IVD Infectious Disease, Product and Application

Table 26. Global Key Players of IVD Infectious Disease, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global IVD Infectious Disease Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global IVD Infectious Disease Revenue Market Share by Type (2020-2025)

Table 30. Global IVD Infectious Disease Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global IVD Infectious Disease Revenue Market Share by Type (2026-2031)

Table 32. Global IVD Infectious Disease Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global IVD Infectious Disease Revenue Market Share by Application (2020-2025)

Table 34. Global IVD Infectious Disease Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global IVD Infectious Disease Revenue Market Share by Application (2026-2031)

Table 36. North America IVD Infectious Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America IVD Infectious Disease Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America IVD Infectious Disease Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe IVD Infectious Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe IVD Infectious Disease Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe IVD Infectious Disease Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific IVD Infectious Disease Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific IVD Infectious Disease Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific IVD Infectious Disease Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America IVD Infectious Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America IVD Infectious Disease Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America IVD Infectious Disease Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa IVD Infectious Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa IVD Infectious Disease Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa IVD Infectious Disease Market Size by Country (2026-2031) & (US$ Million)

Table 51. Roche Diagnostics Company Details

Table 52. Roche Diagnostics Business Overview

Table 53. Roche Diagnostics IVD Infectious Disease Product

Table 54. Roche Diagnostics Revenue in IVD Infectious Disease Business (2020-2025) & (US$ Million)

Table 55. Roche Diagnostics Recent Development

Table 56. Abbott Laboratories Company Details

Table 57. Abbott Laboratories Business Overview

Table 58. Abbott Laboratories IVD Infectious Disease Product

Table 59. Abbott Laboratories Revenue in IVD Infectious Disease Business (2020-2025) & (US$ Million)

Table 60. Abbott Laboratories Recent Development

Table 61. Gen-Probe Company Details

Table 62. Gen-Probe Business Overview

Table 63. Gen-Probe IVD Infectious Disease Product

Table 64. Gen-Probe Revenue in IVD Infectious Disease Business (2020-2025) & (US$ Million)

Table 65. Gen-Probe Recent Development

Table 66. Becton Dickinson (BD) Company Details

Table 67. Becton Dickinson (BD) Business Overview

Table 68. Becton Dickinson (BD) IVD Infectious Disease Product

Table 69. Becton Dickinson (BD) Revenue in IVD Infectious Disease Business (2020-2025) & (US$ Million)

Table 70. Becton Dickinson (BD) Recent Development

Table 71. Bio-Rad Laboratories Company Details

Table 72. Bio-Rad Laboratories Business Overview

Table 73. Bio-Rad Laboratories IVD Infectious Disease Product

Table 74. Bio-Rad Laboratories Revenue in IVD Infectious Disease Business (2020-2025) & (US$ Million)

Table 75. Bio-Rad Laboratories Recent Development

Table 76. Siemens Healthcare Company Details

Table 77. Siemens Healthcare Business Overview

Table 78. Siemens Healthcare IVD Infectious Disease Product

Table 79. Siemens Healthcare Revenue in IVD Infectious Disease Business (2020-2025) & (US$ Million)

Table 80. Siemens Healthcare Recent Development

Table 81. Biomérieux Company Details

Table 82. Biomérieux Business Overview

Table 83. Biomérieux IVD Infectious Disease Product

Table 84. Biomérieux Revenue in IVD Infectious Disease Business (2020-2025) & (US$ Million)

Table 85. Biomérieux Recent Development

Table 86. Danaher Company Details

Table 87. Danaher Business Overview

Table 88. Danaher IVD Infectious Disease Product

Table 89. Danaher Revenue in IVD Infectious Disease Business (2020-2025) & (US$ Million)

Table 90. Danaher Recent Development

Table 91. Thermo Fisher Company Details

Table 92. Thermo Fisher Business Overview

Table 93. Thermo Fisher IVD Infectious Disease Product

Table 94. Thermo Fisher Revenue in IVD Infectious Disease Business (2020-2025) & (US$ Million)

Table 95. Thermo Fisher Recent Development

Table 96. Sysmex Company Details

Table 97. Sysmex Business Overview

Table 98. Sysmex IVD Infectious Disease Product

Table 99. Sysmex Revenue in IVD Infectious Disease Business (2020-2025) & (US$ Million)

Table 100. Sysmex Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. IVD Infectious Disease Picture

Figure 2. Global IVD Infectious Disease Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global IVD Infectious Disease Market Share by Type: 2024 VS 2031

Figure 4. Biochemical Diagnosis Features

Figure 5. Immune Diagnosis Features

Figure 6. Molecular Diagnosis Features

Figure 7. Microbiological Diagnosis Features

Figure 8. Urine Diagnosis Features

Figure 9. Coagulation Diagnosis Features

Figure 10. Other Features

Figure 11. Global IVD Infectious Disease Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global IVD Infectious Disease Market Share by Application: 2024 VS 2031

Figure 13. Personal Case Studies

Figure 14. Commercial Case Studies

Figure 15. Academic Case Studies

Figure 16. Other Case Studies

Figure 17. IVD Infectious Disease Report Years Considered

Figure 18. Global IVD Infectious Disease Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global IVD Infectious Disease Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global IVD Infectious Disease Market Share by Region: 2024 VS 2031

Figure 21. Global IVD Infectious Disease Market Share by Players in 2024

Figure 22. Global Top IVD Infectious Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Disease as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by IVD Infectious Disease Revenue in 2024

Figure 24. North America IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America IVD Infectious Disease Market Share by Country (2020-2031)

Figure 26. United States IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe IVD Infectious Disease Market Share by Country (2020-2031)

Figure 30. Germany IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific IVD Infectious Disease Market Share by Region (2020-2031)

Figure 38. China IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America IVD Infectious Disease Market Share by Country (2020-2031)

Figure 46. Mexico IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa IVD Infectious Disease Market Share by Country (2020-2031)

Figure 50. Turkey IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE IVD Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Roche Diagnostics Revenue Growth Rate in IVD Infectious Disease Business (2020-2025)

Figure 54. Abbott Laboratories Revenue Growth Rate in IVD Infectious Disease Business (2020-2025)

Figure 55. Gen-Probe Revenue Growth Rate in IVD Infectious Disease Business (2020-2025)

Figure 56. Becton Dickinson (BD) Revenue Growth Rate in IVD Infectious Disease Business (2020-2025)

Figure 57. Bio-Rad Laboratories Revenue Growth Rate in IVD Infectious Disease Business (2020-2025)

Figure 58. Siemens Healthcare Revenue Growth Rate in IVD Infectious Disease Business (2020-2025)

Figure 59. Biomérieux Revenue Growth Rate in IVD Infectious Disease Business (2020-2025)

Figure 60. Danaher Revenue Growth Rate in IVD Infectious Disease Business (2020-2025)

Figure 61. Thermo Fisher Revenue Growth Rate in IVD Infectious Disease Business (2020-2025)

Figure 62. Sysmex Revenue Growth Rate in IVD Infectious Disease Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions